Exergaming and mediterranean diet tested for thyroid cancer recovery
NCT ID NCT05265819
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether playing active video games (exergaming) and following a Mediterranean diet could help people who had their thyroid removed due to cancer. 80 adults were split into four groups: one did exergaming, one followed the diet, one did both, and one had no extra intervention. The goal was to see if these lifestyle changes could improve immune markers and hormone levels over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- exergaming (Xbox 360 Kinect) and Mediterranean diet
- What this could lead to
- If it works, this could point toward a way to improve immune function and quality of life for thyroid cancer survivors after surgery.
- What could go wrong
- This is a small, completed trial with no phase, so results may not be generalizable. The outcomes are immune markers, not direct health improvements, and the diet and exercise may not show significant benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis of thyroid papillary carcinoma as it is the most common type 2. Treatment with thyroid hormone medication after thyroidectomy 3. Lack of radioactive iodine treatment within the past 6 months 4. Blood hemoglobin level \>10 g/dL. 5. Not taking drugs that could affect their immune function (e.g., immunosuppressants such as cyclosporin and steroids . 6. Lack of regular exercise 7. Age 18\~45 years 8. Dose should be controlled at the first one year \- Exclusion Criteria: 1\) Abscess or inflammation suspected by preoperative tests 2) Patients with stage IV cancer and with limited understanding of assessment systems 3) History of head or neck malignancy . 4) Radiation therapy 5) Graves disease 6) Thyroiditis 7) Orthopaedic and rheumatic conditions of the neck . 8) The patient's inability to cooperate \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Thyroid cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nabil Mahmoud
Cairo, Giza Governorate, 11829, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Based probe aims to spot thyroid cancer faster
- Mapping how thyroid tumors spread and what surgery leaves behind
- Can a video keep thyroid cancer patients on track after surgery?
- Can doctors safely watch small thyroid cancers instead of removing them?
- Can heat replace the scalpel for small thyroid tumors?
- Thyroid surgery under the microscope: what 3,000 real operations reveal